Corient Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$9.15M Hold
101,932
0.68% 30
2022
Q2
$9.15M Sell
101,932
-5,314
-5% -$477K 0.69% 32
2022
Q1
$11.9M Buy
107,246
+579
+0.5% +$64.2K 0.79% 20
2021
Q4
$11M Buy
106,667
+8,450
+9% +$874K 0.73% 22
2021
Q3
$12.3M Buy
98,217
+11,609
+13% +$1.46M 0.9% 15
2021
Q2
$10.8M Buy
86,608
+11,254
+15% +$1.4M 0.79% 18
2021
Q1
$8.9M Buy
75,354
+1,553
+2% +$183K 0.76% 18
2020
Q4
$8.65M Buy
73,801
+1,274
+2% +$149K 0.86% 18
2020
Q3
$7.54M Buy
72,527
+1,316
+2% +$137K 0.87% 18
2020
Q2
$6.53M Buy
71,211
+15,996
+29% +$1.47M 0.8% 26
2020
Q1
$4.98M Sell
55,215
-3,060
-5% -$276K 0.79% 28
2019
Q4
$6.61M Buy
58,275
+1,465
+3% +$166K 0.84% 20
2019
Q3
$6.17M Buy
56,810
+1,856
+3% +$202K 0.87% 18
2019
Q2
$5.35M Buy
54,954
+476
+0.9% +$46.4K 0.82% 18
2019
Q1
$4.96M Sell
54,478
-3,938
-7% -$359K 0.81% 18
2018
Q4
$5.31M Buy
58,416
+26,518
+83% +$2.41M 0.95% 14
2018
Q3
$3.14M Hold
31,898
0.52% 47
2018
Q2
$2.73M Buy
31,898
+9,580
+43% +$820K 0.48% 64
2018
Q1
$1.79M Buy
22,318
+3,604
+19% +$289K 0.33% 88
2017
Q4
$1.51M Buy
18,714
+1,685
+10% +$136K 0.26% 97
2017
Q3
$1.33M Sell
17,029
-5
-0% -$389 0.25% 98
2017
Q2
$1.51M Buy
17,034
+1,120
+7% +$99.4K 0.23% 110
2017
Q1
$1.28M Buy
15,914
+3,255
+26% +$262K 0.2% 119
2016
Q4
$902K Sell
12,659
-1,860
-13% -$133K 0.16% 138
2016
Q3
$1.25M Buy
+14,519
New +$1.25M 0.23% 110